Read + Share
Amedeo Smart
Independent Medical Education
Ryu DB, Lim JY, Kim TW, Shin S, et al. Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease. Exp Hematol 2021 Mar 31. pii: S0301-472X(21)00129.PMID: 33811972
Email
LinkedIn
Facebook
Twitter
Privacy Policy